美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

Methylcobalamin

HUMAN COMPOUNDED DRUG

67157-006

McGuff Outsourcing Solutions

2024-2

METHYLCOBALAMIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

30 mg

67157-006-30

TESTOSTERONE CYPIONATE 200 MG/ML MIGLYOL 812N 30ML NDC 73271-1226-2

HUMAN COMPOUNDED DRUG

73271-1226

Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals

2024-2

TESTOSTERONE CYPIONATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.2 g

73271-1226-2

TESTOSTERONE CYPIONATE/PROPIONATE 200 MG/10 MG/ML MIGLYOL 812N

HUMAN COMPOUNDED DRUG

73271-1229

Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals

2024-2

TESTOSTERONE CYPIONATE; TESTOSTERONE PROPIONATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg/1 mL; 10 mg/1 mL

73271-1229-1

TESTOSTERONE CYPIONATE 200 MG/ML MIGLYOL 812N 5ML NDC 73271-1225-1

HUMAN COMPOUNDED DRUG

73271-1225

Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals

2024-2

TESTOSTERONE CYPIONATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.2 g

73271-1225-1

TESTOSTERONE SA2 25MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg

70713-006-01

ESTRADIOL 6MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

6 mg

70713-050-01

Dexmedetomidine Hydrochloride

HUMAN COMPOUNDED DRUG

71449-131

Denver Solutions, LLC dba Leiters Health

2024-2

DEXMEDETOMIDINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4 ug/1 mL

71449-131-11

Dexmedetomidine Hydrochloride

HUMAN COMPOUNDED DRUG

71449-131

Denver Solutions, LLC dba Leiters Health

2024-2

DEXMEDETOMIDINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4 ug/1 mL

71449-131-15

Succinylcholine Chloride

HUMAN COMPOUNDED DRUG

71449-126

Denver Solutions, LLC dba Leiters Health

2024-2

SUCCINYLCHOLINE CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/1 mL

71449-126-15

Lidocaine Hydrochloride

HUMAN COMPOUNDED DRUG

71449-023

Denver Solutions, LLC dba Leiters Health

2024-2

LIDOCAINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

71449-023-11

Lidocaine Hydrochloride, Phenylephrine Hydrochloride

HUMAN COMPOUNDED DRUG

71449-090

Denver Solutions, LLC dba Leiters Health

2024-2

LIDOCAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL; 15 mg/1 mL

71449-090-42

Moxifloxacin Hydrochloride

HUMAN COMPOUNDED DRUG

71449-096

Denver Solutions, LLC dba Leiters Health

2024-2

MOXIFLOXACIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

71449-096-42

Moxifloxacin Hydrochloride

HUMAN COMPOUNDED DRUG

71449-096

Denver Solutions, LLC dba Leiters Health

2024-2

MOXIFLOXACIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

71449-096-03

Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag

HUMAN COMPOUNDED DRUG

72196-0431

Central Admixture Pharmacy Services, Inc.

2024-2

HEPARIN SODIUM; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

125 U/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL

72196-0431-1

Modified St. Thomas Low K (62 mEq) High Sodium Bicarbonate 1000 mL Bag

HUMAN COMPOUNDED DRUG

71285-0203

Central Admixture Pharmacy Services, Inc.

2024-2

SODIUM CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; CALCIUM CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 meq/1000 mL; 29.232 meq/1000 mL; 62 meq/1000 mL; 3.864 g/1000 mL; 2.176 meq/1000 mL

71285-0203-1

Maintenance 4 to1 Low K (12 meq) in LR

HUMAN COMPOUNDED DRUG

71285-0205

Central Admixture Pharmacy Services, Inc.

2024-2

MANNITOL; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

31.26 g/504.8 mL; 250 mg/504.8 mL; .924 g/504.8 mL; 2.743 g/504.8 mL; .99 g/504.8 mL; .105 g/504.8 mL

71285-0205-1

Phenylephrine 40mg added to NS

HUMAN COMPOUNDED DRUG

71285-6092

Central Admixture Pharmacy Services, Inc.

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

40 mg/250 mL

71285-6092-1

Diltiazem 125mg added to NS

HUMAN COMPOUNDED DRUG

71285-6055

Central Admixture Pharmacy Services, Inc.

2024-2

DILTIAZEM HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

125 mg/125 mL

71285-6055-1

Heparin 4000units added to NS

HUMAN COMPOUNDED DRUG

71285-7022

Central Admixture Pharmacy Services, Inc.

2024-2

HEPARIN SODIUM

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4000 U/1000 mL

71285-7022-1

Induction 4 to1 High K (36mEq) Low Tromethamine 500ml Bag

HUMAN COMPOUNDED DRUG

71285-0101

Central Admixture Pharmacy Services, Inc.

2024-2

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM CHLORIDE; TROMETHAMINE; POTASSIUM CHLORIDE; DEXTROSE MONOHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.666 g/500 mL; 13.92 g/500 mL; .981 g/500 mL; 7.89 g/500 mL; 13.6 meq/500 mL; 2.16 g/500 mL; 36 meq/500 mL; 19.6 g/500 mL

71285-0101-1

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：